Digital Health Europe

Europe Precision Medicine Platforms Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Precision Medicine Platforms Market Industry Trends and Forecast to 2034: Segmented by (Component, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.93 Bn Placeholder estimate
Estimate 2025 $2.12 Bn 19.1% of the global market
Projected 2034 $4.92 Bn 132% Adds $2.80 Bn over 9 forecast years
CAGR 2025–2034 9.8% Faster than 20% of 100 Digital Health markets here
Key players 5
  • Europe is 19.12% of the global market.
  • Among regions, the largest is North America at $5.14 Bn.
  • Fastest growing: APAC at 12.6% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.80 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Precision Medicine Platforms Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.93 Bn — —
2025 (base) $2.12 Bn +$189.2 Mn —
2026 (forecast) $2.33 Bn +$207.7 Mn +9.8%
2027 (forecast) $2.56 Bn +$228.1 Mn +20.6%
2028 (forecast) $2.81 Bn +$250.4 Mn +32.4%
2029 (forecast) $3.08 Bn +$275.0 Mn +45.3%
2030 (forecast) $3.38 Bn +$301.9 Mn +59.6%
2031 (forecast) $3.71 Bn +$331.5 Mn +75.2%
2032 (forecast) $4.08 Bn +$364.0 Mn +92.4%
2033 (forecast) $4.48 Bn +$399.7 Mn +111.3%
2034 (forecast) $4.92 Bn +$438.9 Mn +132%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Precision Medicine Platforms Market Analysis at a glance
Market size, 2025$2.12 Bn placeholder estimate
Forecast, 2034$4.92 Bn placeholder estimate
Growth (CAGR), 2025–20349.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsComponent, application and end user (see all)
Key playersTempus, Illumina, Inc., Roche, Caris Life Sciences, Sophia Genetics (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Precision Medicine Platforms Market Analysis Executive Summary

Precision medicine platforms combine genetic, clinical and lifestyle data to tailor treatment and prevention to each person.

Key segments of the precision Medicine Platforms market include component (Software Platforms, Data Services and Testing Services) and application (Oncology, Cardiology and Rare Disease).

Bar chart: Europe Precision Medicine Platforms market size, 2024–2034, placeholder estimates. $1.93 Bn in 2024, $2.12 Bn in 2025 and $4.92 Bn in 2034, 9.8% CAGR.
Europe Precision Medicine Platforms market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Precision Medicine Platforms Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the precision Medicine Platforms market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the precision Medicine Platforms market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the precision Medicine Platforms market.

Competitive Landscape for Precision Medicine Platforms Market in Europe

The precision Medicine Platforms market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Precision Medicine Platforms Market in Europe

Precision Medicine Platforms in Europe: rules and payment

Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.⁠[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)⁠[1], BfArM (DiGA) (Germany)⁠[2], EU MDR and Ministry of Health (Italy)⁠[1], EU MDR and AEMPS (Spain)⁠[1] and MHRA (UK)⁠[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[4]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] BfArM DiGA directory. Checked 14 Nov 2026.

[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[4] European Commission, health technology assessment. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the precision Medicine Platforms market. Government digital health programs in Europe are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Precision Medicine Platforms right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Precision Medicine Platforms in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Precision Medicine Platforms market in Europe?
Placeholder estimate: about $2.12 Bn in 2025, rising to about $4.92 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Precision Medicine Platforms market in Europe growing?
Placeholder estimate: about 9.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Precision Medicine Platforms market report cover?
The report splits the market by component (Software Platforms, Data Services, Testing Services), application (Oncology, Cardiology, Rare Disease, Pharmacogenomics) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Precision Medicine Platforms market?
Key players include Tempus, Illumina, Inc., Roche, Caris Life Sciences and Sophia Genetics.
What is driving the Precision Medicine Platforms market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the precision Medicine Platforms market.
Who regulates Precision Medicine Platforms in Europe?
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How much research is published on Precision Medicine Platforms?
PubMed lists 20 papers on Precision Medicine Platforms added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Europe

See all

Related on genomics and health it and data

See the topic